InvestorsHub Logo
Followers 1
Posts 136
Boards Moderated 0
Alias Born 10/27/2016

Re: None

Friday, 12/30/2016 5:45:32 PM

Friday, December 30, 2016 5:45:32 PM

Post# of 18268
Happy New Year

I hope other investments in 2017 treat HDC shareholders better than HDC has treated us over the years. It's hard to fathom that we would be ending the year with the stock price at .013, particularly with Neo having commercialized the prostate test. This doesn't seem plausible, but HDC has proven that it can do anything to disappoint.

Since the company has indicated that it will run out of money by the end of Q1, it should be interesting to see if they quietly turn out the lights, or issue a less-than-credible announcement about suing Neo for not providing HDC with royalties. In any event, since Neo hasn't issued a press release on a test that they invested handsomely in, my guess is that they came to realize the test isn't going to be a game changer after all.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HDVY News